265 related articles for article (PubMed ID: 25961578)
1. Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration.
García de la Mària C; Cervera C; Pericàs JM; Castañeda X; Armero Y; Soy D; Almela M; Ninot S; Falces C; Mestres CA; Gatell JM; Moreno A; Marco F; Miró JM;
PLoS One; 2015; 10(5):e0125818. PubMed ID: 25961578
[TBL] [Abstract][Full Text] [Related]
2. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
[TBL] [Abstract][Full Text] [Related]
3. hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre.
Maor Y; Belausov N; Ben-David D; Smollan G; Keller N; Rahav G
Clin Microbiol Infect; 2014 Oct; 20(10):O730-6. PubMed ID: 24329974
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
5. Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.
Carugati M; Petti CA; Arnold C; Miro JM; Pericàs JM; Garcia de la Maria C; Kanafani Z; Durante-Mangoni E; Baddley J; Wray D; Klein JL; Delahaye F; Fernandez-Hidalgo N; Hannan MM; Murdoch D; Bayer A; Chu VH
Antimicrob Agents Chemother; 2016 Oct; 60(10):6341-9. PubMed ID: 27527083
[TBL] [Abstract][Full Text] [Related]
6. Coagulase-negative staphylococcal bloodstream infections: Does vancomycin remain appropriate empiric therapy?
Valencia-Rey P; Weinberg J; Miller NS; Barlam TF
J Infect; 2015 Jul; 71(1):53-60. PubMed ID: 25725152
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors associated with 30-day in-hospital mortality in coagulase-negative Staphylococcus bacteraemia: no impact of vancomycin minimum inhibitory concentration.
Hentzien M; Strady C; Vernet-Garnier V; Servettaz A; De Champs C; Delmer A; Bani-Sadr F; N'Guyen Y
Infect Dis (Lond); 2017 Sep; 49(9):664-673. PubMed ID: 28490261
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant
Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
[No Abstract] [Full Text] [Related]
9. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
Hidalgo-Tenorio C; Gálvez J; Martínez-Marcos FJ; Plata-Ciezar A; De La Torre-Lima J; López-Cortés LE; Noureddine M; Reguera JM; Vinuesa D; García MV; Ojeda G; Luque R; Lomas JM; Lepe JA; de Alarcón A
BMC Infect Dis; 2020 Feb; 20(1):160. PubMed ID: 32085732
[TBL] [Abstract][Full Text] [Related]
11. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
Harper T; Miller D; Flynn HW
Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
[TBL] [Abstract][Full Text] [Related]
13. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.
Chu VH; Woods CW; Miro JM; Hoen B; Cabell CH; Pappas PA; Federspiel J; Athan E; Stryjewski ME; Nacinovich F; Marco F; Levine DP; Elliott TS; Fortes CQ; Tornos P; Gordon DL; Utili R; Delahaye F; Corey GR; Fowler VG;
Clin Infect Dis; 2008 Jan; 46(2):232-42. PubMed ID: 18171255
[TBL] [Abstract][Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
[TBL] [Abstract][Full Text] [Related]
15. Methicillin and vancomycin resistance in coagulase-negative Staphylococci isolated from the nostrils of hospitalized patients.
Al-Tamimi M; Abu-Raideh J; Himsawi N; Khasawneh A; Hawamdeh H
J Infect Dev Ctries; 2020 Jan; 14(1):28-35. PubMed ID: 32088681
[TBL] [Abstract][Full Text] [Related]
16. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
17. Trends of Antimicrobial Susceptibility in Clinically Significant Coagulase-Negative Staphylococci Isolated from Cerebrospinal Fluid Cultures in Neurosurgical Adults: a Nine-Year Analysis.
Ye Y; Tian Y; Kong Y; Ma J; Shi G
Microbiol Spectr; 2022 Feb; 10(1):e0146221. PubMed ID: 35138154
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and body site distribution of community isolates of coagulase-negative staphylococci.
Cavanagh JP; Wolden R; Heise P; Esaiassen E; Klingenberg C; Aarag Fredheim EG
APMIS; 2016 Nov; 124(11):973-978. PubMed ID: 27599662
[TBL] [Abstract][Full Text] [Related]
19. One-year mortality in coagulase-negative Staphylococcus and Staphylococcus aureus infective endocarditis.
Rasmussen RV; Snygg-Martin U; Olaison L; Andersson R; Buchholtz K; Larsen CT; Hansen TF; Køber L; Hassager C; Bruun NE
Scand J Infect Dis; 2009; 41(6-7):456-61. PubMed ID: 19396665
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
Krediet TG; Jones ME; Gerards LJ; Fleer A
Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
